sec filing
DM
NASDAQ · DMAA
Drugs Made In America Acquisition Corp. Ordinary Shares
Financial Services · Shell Companies
$10.84
Down-$0.00 (-0.01%)
Updated Sep 16, 2026, 2:19 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 347.24M
- P/E ratio
- 41.6
- Dividend yield
- 0.00%
- 52-week range
- $10.22 – $10.86
- Volume
- 1.55K
- Avg. volume
- 35.26K
Price performance
DMAA price history
1M range · 20 trading sessions · Daily adjusted prices
DMAA closed at $10.84 after 20 trading sessions, up 1.12% for the selected period.
- Last close
- $10.84
- Period change
- +1.12%
- Period low
- $10.72
- Period high
- $10.84
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $10.84 | $10.84 | $10.8371 | $10.84 | 1.55K |
| Sep 14, 2026 | $10.80 | $10.855 | $10.80 | $10.83 | 164.45K |
| Sep 11, 2026 | $10.795 | $10.80 | $10.795 | $10.80 | 802.09 |
| Sep 10, 2026 | $10.80 | $10.80 | $10.79 | $10.80 | 34.84K |
| Sep 9, 2026 | $10.80 | $10.80 | $10.7877 | $10.80 | 3.24K |
| Sep 8, 2026 | $10.76 | $10.79 | $10.755 | $10.79 | 519.52K |
| Sep 4, 2026 | $10.76 | $10.765 | $10.75 | $10.76 | 29.71K |
| Sep 3, 2026 | $10.75 | $10.75 | $10.75 | $10.75 | 109 |
| Sep 2, 2026 | $10.755 | $10.765 | $10.75 | $10.76 | 18.22K |
| Sep 1, 2026 | $10.745 | $10.76 | $10.745 | $10.755 | 27.99K |
| Aug 31, 2026 | $10.74 | $10.755 | $10.74 | $10.75 | 4.13K |
| Aug 28, 2026 | $10.75 | $10.75 | $10.74 | $10.75 | 4.23K |
| Aug 27, 2026 | $10.75 | $10.76 | $10.75 | $10.76 | 16.92K |
| Aug 26, 2026 | $10.76 | $10.76 | $10.75 | $10.76 | 12.3K |
| Aug 25, 2026 | $10.75 | $10.76 | $10.74 | $10.76 | 15.14K |
| Aug 24, 2026 | $10.76 | $10.76 | $10.74 | $10.74 | 25.14K |
| Aug 21, 2026 | $10.73 | $10.75 | $10.73 | $10.75 | 82.32K |
| Aug 20, 2026 | $10.71 | $10.73 | $10.71 | $10.725 | 1.73K |
| Aug 19, 2026 | $10.70 | $10.72 | $10.70 | $10.72 | 4.13K |
| Aug 18, 2026 | $10.72 | $10.72 | $10.72 | $10.72 | 296 |
Latest DMAA news
The latest Smart Investors Daily articles mentioning DMAA.
Stock researchCompany · Overview
DMAA research
Overview
Company profile and research snapshot.
Company profile
Drugs Made In America Acquisition Corp is a blank check company.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.